Reblozyl was initially approved as an alternative second-line treatment for anemia in MDS with ring sideroblasts (MDS-RS) ...

A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be ...

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic ...

Patients suffer from anemia—a lack of red blood ... who fall into the lower-risk category of MDS and who do not respond to standard treatment with epoetin alfa," says study leader Professor ...

You may need to undergo other treatments for MDS before your transplant ... Even if it improves the hemoglobin level and the anemia gets better, it will actually decrease levels of neutrophils. This ...

aplastic anemia certain leukemias, including acute leukemia and large granular lymphocytic leukemia HIV infection an overactive immune system Proper diagnosis is crucial so that you receive the ...

as well as recombinant human erythropoietin to treat symptomatic anemia. Low-intensity chemotherapy or biological-response modifiers have been used in the treatment of MDS, principally in clinical ...